Many chain pharmacies sell their certificates and delist

For small and medium-sized chain pharmacies, delisting of certificates may become the norm

A chain headquarters, cancel the "drug business license"

Recently, Inner Mongolia Food and Drug Administration official website announced that, according to relevant regulations, the council for review in accordance with legal procedures, agreed Bayannao'er Huifeng Guoyao large pharmacy chain Limited "Drug License" written off

(Picture information: intercepted to the official website of Inner Mongolia Drug Administration)

According to the company's information, Bayannaoer Huifeng National Pharmaceutical Pharmacy Chain Co.

It is a subsidiary of Inner Mongolia Huifeng Sinopharm Pharmacy Chain Co.

(Source of picture information: Intercepted to Qichacha)

The author noticed that on June 16 this year, Bayannaoer Huifeng National Pharmaceutical Pharmacy Chain Co.

(Picture information: intercepted to the official website of Inner Mongolia Drug Administration)

A number of chain pharmacies have been delisted from the market

In fact, there are still many similar cases this year

On May 6 this year, the Yunnan Provincial Food and Drug Administration cancelled the "Drug Distribution License" of Yunnan Jianjun Pharmaceutical Co.

In the same year April 7, Inner Mongolia Food and Drug Administration announced that, in accordance with corporate registration, it shall be conducted according to legal procedures, agreed Cottage Inner Mongolia Kampo Medicine Chain Co.

The Shanxi Provincial Drug Administration issued an announcement earlier that it had cancelled the "Pharmaceutical Operation" of the three chain "Pharmaceutical Management" License

As for why the chain headquarters will be delisted from the market, Li Feng of the Shaanxi Guangjitang Pharmaceutical Group told the author that there are three main reasons

Take Shanxi Baijia Old Pharmacy and Guangshengtang in Houma City as examples.

Small and medium chain, delisting or normalization

According to the latest data from the National Food and Drug Administration, as of the end of March 2021, the number of pharmacies nationwide has exceeded 560,000

Compared with the data at the end of last year, within the first three months of the year, there were 295 more retail chain headquarters and 7,100 more retail stores (including 900 individual stores)

The domestic pharmacy industry has already experienced serious overcapacity, and the supply far exceeds the demand.

At the same time, judging from the current market feedback, mergers and acquisitions by major chains are also very normal.

Li Feng believes that mergers and acquisitions between chains are the result of strong business power but weak business power, and strong capital power beats weak capital power.

In summary, small and medium chains will be further optimized, or eliminated, or taken over by large chains.
.
.
However, often small and medium chains and single stores do not have a regional monopoly status and do not have much acquisition value.
, Even if they want to sell, they don’t have to be
.

The CMH report of Zhongkang pointed out that compared with the average level in 2019, the passenger flow of retail pharmacies in July this year was still sluggish
.
In July, the national average store sales index fixed base and month-on-month index were 87 and 99 respectively.
In July, the overall average sales of retail pharmacies continued to decline
.

"The decline in offline store sales has a lot to do with the continued growth of B2C and O2O sales
.
" He said that the current retail market has become saturated, and online growth will definitely squeeze offline
.
However, when most companies are pouring online, traffic costs increase, and growth will stall
.

He also pointed out that although medicines are special commodities and many offline service lines cannot replace them, pure commodity sales pharmacies do not have supply chain advantages and will become increasingly difficult
.